Cargando…
Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB
Triptolide (TPL) inhibits the proliferation of a variety of cancer cells and has been proposed as an effective anticancer agent. In this study, we demonstrate that TPL downregulates HER2 protein expression in oral, ovarian, and breast cancer cells. It suppresses HER2 protein expression in a dose- an...
Autores principales: | Ou, Chien-Chih, Chen, Yuan-Wu, Hsu, Shih-Chung, Sytwu, Huey-Kang, Loh, Shih-Hurng, Li, Jhy-Wei, Liu, Jah-Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543825/ https://www.ncbi.nlm.nih.gov/pubmed/23346199 http://dx.doi.org/10.1155/2012/350239 |
Ejemplares similares
-
Triptolide represses oral cancer cell proliferation, invasion, migration, and angiogenesis in co-inoculation with U937 cells
por: Yang, Cheng-Yu, et al.
Publicado: (2016) -
Ganoderma tsugae Extract Inhibits Growth of HER2-Overexpressing Cancer Cells via Modulation of HER2/PI3K/Akt Signaling Pathway
por: Kuo, Han-Peng, et al.
Publicado: (2013) -
A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers
por: Lee, Yi-Jen, et al.
Publicado: (2016) -
Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism
por: Zhang, Weiying, et al.
Publicado: (2016) -
The Antigastric Cancer Effect of Triptolide is Associated With H19/NF-κB/FLIP Axis
por: Yuan, Weiwei, et al.
Publicado: (2022)